We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sysmex Signs Agreement with Labcorp for Hematology System

By LabMedica International staff writers
Posted on 27 Sep 2010
Sysmex America, Inc., (Mundelein, Illinois, USA) have signed a five year agreement with Laboratory Corporation of America (LabCorp; Burlington, NC, USA) to provide fully automated hematology systems. More...


Sysmex America, Inc., is a leading medical diagnostic instrument manufacturer and information systems developer, has supplied LabCorp with hematology systems for their primary testing laboratories. Implementation of the systems has been completed.

The hematology systems purchased by LabCorp include Sysmex HST- Hematology Automation Systems comprised of XE-Series Automated Hematology Analyzers, Sysmex SP-1000 Automated Slidemaker/Stainers and Sysmex-distributed CellaVision DM96 Automated Digital Cell Morphology Systems. Sysmex WAM Decision Support Software for the Clinical Laboratory will bring rules-based intelligence to these automation systems by consolidating data from these multiple instruments and performing expert rules-based functions and results management.

The HST-N systems are linked to the AutoSorter II by Motoman, Inc., (West Carrollton, OH, USA). The HST-N systems will also utilize Sysmex's RU-10 Reagent Production System, specifically designed for the Commercial Reference Laboratory, which prepares some of the required analyzer reagents on site, on demand, to help balance inventory and reduce storage space requirements.

John Kershaw, president and CEO of Sysmex America, Inc., said, "We are honored to serve as LabCorp's strategic business partner in its endeavor to provide a new 'intelligent' diagnostic service offering. We trust our innovative automated solutions will provide an unparalleled level of optimization that streamlines operations while providing quality, connectivity and an enhanced service offering."

Related Links:
Sysmex America, Inc
LabCorp
Motoman, Inc



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.